ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,049.88
0.05%
Dow Jones
44,705.53
-0.17%
US Dollar vs MXN
20.37125
0.26%
Brent Oil
73.845
0.33%
Bitcoin
96,899.42
0.97%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Aegon Ltd (AGN) Cotización

Aegon Ltd

Aegon Ltd (AGN)

Argenica Therapeutics Limited
Algernon Pharmaceuticals Inc
6.208
0.148
( 2.44% )
Actualizado: 03:34:46
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
6.208
Postura de Compra
6.206
Postura de Venta
6.208
Volume Operado de la Acción
1,757,519
6.076 Rango del Día 6.214
5.056 Rango de 52 semanas 6.418
Capitalización de Mercado [m]
13.685B
Precio Anterior
6.06
Precio de Apertura
6.078
Hora
640
@
6.208
Última hora de negociación
03:34:44
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
4,297,881
Acciones en circulación
2,204,486,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-73.15
Beneficio por acción (BPA)
-0.08
turnover
24.96B
Beneficio neto
-179M

Acerca de Aegon Ltd

Sector
Ins Agents,brokers & Service
Industria
Ins Agents,brokers & Service
Sitio web
www.aegon.com
Sede
The Hague, South Holland, Nld
Fundado
-
Aegon Ltd is listed in the Ins Agents,brokers & Service sector of the Euronext with ticker AGN. The last closing price for Aegon was 6.06 €. Over the last year, Aegon shares have traded in a share price range of 5.056 € to 6.418 €.

Aegon currently has 2,204,486,000 shares in issue. The market capitalisation of Aegon is 13.36 € billion. Aegon has a price to earnings ratio (PE ratio) of -73.15.

AGN Últimas noticias

Más noticias

Redomiciliation to Bermuda completed

Redomiciliation to Bermuda completed The Hague, September 30, 2023 - Aegon’s Extraordinary General Meeting of shareholders (EGM) today approved the cross-border conversion into a Bermuda...

30 Septiembre 2023
GlobeNewswire Inc.

Extraordinary General Meeting approves first step in redomiciliation to Bermuda

Extraordinary General Meeting approves first step in redomiciliation to Bermuda The Hague, September 29, 2023 - Aegon’s Extraordinary General Meeting of shareholders (EGM) today approved the...

29 Septiembre 2023
GlobeNewswire Inc.

Aegon publishes agenda for Extraordinary General Meetings on September 29 and September 30, 2023

Aegon publishes agenda for Extraordinary General Meetings on September 29 and September 30, 2023 The Hague, August 17, 2023 - Today, Aegon N.V. has published the Agenda and Shareholder...

17 Agosto 2023
GlobeNewswire Inc.

Aegon reports first half year 2023 results

Aegon reports first half year 2023 results Please click here to access all 1H2023 results related documents The Hague, August 17, 2023 - Starting the next chapter of Aegon’s transformation...

17 Agosto 2023
GlobeNewswire Inc.

Aegon announces determination of the coupon rate for Perpetual Capital Securities

Aegon announces determination of the coupon rate for Perpetual Capital Securities The Hague, July 17, 2023 - Aegon today announces that a coupon rate of 3.93894% has been determined for the...

17 Julio 2023
GlobeNewswire Inc.

Aegon begins share buyback program

Aegon begins share buyback program The Hague, July 6, 2023 - Aegon today announces the beginning of a EUR 1.5 billion share buyback program. This follows the completion of the combination of...

06 Julio 2023
GlobeNewswire Inc.

La Banque Postale and Aegon extend their partnership in asset management

La Banque Postale and Aegon extend their partnership in asset management The Hague, July 4, 2023 - La Banque Postale and Aegon Asset Management (Aegon AM) are pleased to announce the...

04 Julio 2023
GlobeNewswire Inc.

Aegon completes transaction with a.s.r.

Aegon completes transaction with a.s.r. The Hague, July 4, 2023 - Aegon today announces the completion of the combination of its Dutch pension, life and non-life insurance, banking, and...

04 Julio 2023
GlobeNewswire Inc.

Aegon’s group supervision to transfer from Dutch Central Bank to Bermuda Monetary Authority

Aegon’s group supervision to transfer from Dutch Central Bank to Bermuda Monetary Authority Aegon’s legal domicile to be transferred to Bermuda. Consequently, group supervision to move from...

30 Junio 2023
GlobeNewswire Inc.

Capital Markets Day 2023: Transforming Aegon – The Next Chapter

Capital Markets Day 2023: Transforming Aegon – The Next Chapter Aegon to accelerate its strategy to create leading businesses in investment, protection and retirement solutions Transamerica...

22 Junio 2023
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.325.43478260875.8886.2145.84438479116.03255285DE
40.0881.437908496736.126.2985.84447098086.05948578DE
120.82415.30460624075.3846.2985.31642978815.83282825DE
260.2624.406323578885.9466.2985.19245360275.76402906DE
521.14422.59083728285.0646.4185.05653699305.63868463DE
1562.18354.23602484474.0256.4183.5974021264.82791255DE
2602.28558.24624012243.9236.4181.55697120153.90875526DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALCOXNicox SA
0.284 €
(29.98%)
641.53k
VACBSPierre & Vacances
0.073 €
(21.67%)
38.08k
ALNMRNamR SA
0.518 €
(17.73%)
408
ABEOABEO SA
10.50 €
(15.64%)
7.21k
ALINSIntrasense
0.317 €
(14.03%)
257.55k
ALTMENoxxon Pharma NV
0.097 €
(-37.58%)
2.44M
ALVETEGEIRO Pharma
0.091 €
(-26.61%)
120.09k
ALALOAcheterLouerFR
0.4012 €
(-19.74%)
4.6k
ATOAtos SE
0.4013 €
(-18.93%)
4.66M
ALBIOBiosynex
1.782 €
(-14.94%)
17.27k
ALNEVNeovacs
0.0003 €
(0.00%)
16.73M
ATOAtos SE
0.4013 €
(-18.93%)
4.66M
BCPBanco Comercial Portugues SA
0.4448 €
(-0.20%)
3.68M
ALHPIHopium SA
0.0089 €
(3.49%)
3.49M
LATLatecoere
0.0085 €
(4.94%)
3.33M

Discusión

Ver feed completo
PC retired PC retired 6 minutos hace
I am still waiting for a report from Mr S as his installation must now be complete, providing an off-grid solution to the high cost of energy.
FLCX
capgain capgain 7 minutos hace
That was really cool, it made my morning. I missed it yesterday somehow.

Great song too.
MiamiGent MiamiGent 16 minutos hace
This may be fake and or old news
toohot toohot 17 minutos hace
Does Warren Buffett DCA? U Betcha!!!
Among the numerous investment strategies available, dollar-cost averaging is a popular and widely used approach. Its proponents range from Warren Buffett to average investors.
BIEL = Patience




BUY $BIEL$
BIEL
GREGG THE GREEK GREGG THE GREEK 18 minutos hace
Amazing indeed !!!

Top of the morning to all.

MONI




VERY
MONI
MiamiGent MiamiGent 18 minutos hace
This may well be fake and/or old news.
Seminole Red Seminole Red 19 minutos hace
McIlroy expressed hopes last month that Donald Trump's re-election could expedite progress, with the DOJs Antitrust Division posing as the major hurdle in the ongoing golf saga......

https://www.msn.com/en-us/sports/golf/tiger-woods-takes-swipe-at-doj-as-he-gives-update-on-liv-golf-an
toohot toohot 19 minutos hace
Dollar cost averaging is the key here for BIEL. Great entry price as well as an add-on for current holdings.




BUY $BIEL$
BIEL
gregcod gregcod 20 minutos hace
IBAT hired engineer Don Bender of Prairee, which is now bought out and owned by Arizona Lithium..One was guess that the DLE Arizona Lithium will use in Sasquatch land will IBATs..IMO..
IBATF
toohot toohot 23 minutos hace
Let me put this out. Some disgruntled investors need to look to the future. Patience is and still is the key here for BIEL. Watch snd see.




BUY $BIEL$
BIEL
Augster Augster 23 minutos hace
It’s a big world. I know Americans like to think the U.S. is the only market that matters…the rest of the world doesn’t think that way…thankfully either does Vivos.
RDGL
RichieBoy RichieBoy 24 minutos hace
AFFU definitely prefers a low profile. Not just for security reasons (them being a cyber security service as is MTi). But there's a possibility AFFU is a family office type operation. Not unusual for a Family Office to maintain a low profile. As for a holding company I'd say that likelihood is less
AFFU
Wayne R Wayne R 25 minutos hace
Given what I seen recently, NASDAQ rules seem to be simply guidelines and they don't care if they are bent, broken or ignored so long as the listing fees are paid.

Bwtfdik 🤪
VERB
axelvento axelvento 25 minutos hace
04 Dec, 2024Moderna opens world-leading vaccine facility in Victoria

The Southern Hemisphere’s only commercial-scale end-to-end mRNA manufacturing facility has opened in Victoria, backed by both the Australian and Victorian Governments. This landmark development will enable the produc
MRNA
nowwhat2 nowwhat2 28 minutos hace
The implications are clear......Or are they / I dunno / I rarely have bothered to hunt down good charts

https://investorshub.advfn.com/uimage/uploads/2024/12/4/egfwdgc00_121212_hyper_60y_chan_.ca.jpg



The GOOD charts they tend to keep hidden in closets
GOLD
p0 p0 30 minutos hace
Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®
https://valneva.com/press-release/valneva-reports-positive-three-year-antibody-persistence-data-for-its-single-shot-chikungunya-vaccine-ixchiq/
VALN
sam1933 sam1933 31 minutos hace
$HBAR $3 Price TARGET https://youtu.be/txMWlR6_Goo
HBAR
Wayne R Wayne R 33 minutos hace
Can they sell them to a junk yard?

The potentially useless batteries might now be considered an environmental hazard and instead of selling they may have to pay for the destruction.

I have no idea, just a thought.
MULN
TightCoil TightCoil 39 minutos hace
Selling of FNMA or FMCC is NOT PROHIBITED on Wednesday
FMCC
Truthsocial Truthsocial 39 minutos hace
https://andamanmed.com/regulatory-services/medical-device-registration/

Move along Fudsters if you believe this is a small market in Asia huh ...

Much Bigger than US market
Parallel approval coming my money is on Asia happening very quickly as in soon
RDGL
diggitydoodle diggitydoodle 44 minutos hace
Halfway through another week of nothing, thanks to the great CEO.
Meanwhile, the ticker that everyone is watching...dropping like a stone.
But, this is a pumpers paradise. They're the experts. 🤣🤣
RNVA!!$$????????????????????
RNVA
p0 p0 44 minutos hace
Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
https://valneva.com/press-release/valneva-announces-peer-reviewed-publication-on-the-global-health-and-economic-burden-of-chikungunya-in-the-british-medical-journal/
VALN
Truthsocial Truthsocial 46 minutos hace
https://asiaactual.com/indonesia/medical-device-registration/


Looks like we may have a fairly easier quicker device approval forthcoming for RDGL and MAYO clinic...
Outside the people trying to prolong the FDA IDE APPROVAL people trying to line their pockets with GREEN
RDGL
Nrdc92 Nrdc92 49 minutos hace
The company has been managed poorly. At this point, that is abundantly clear. Just as bad, the optics have damaged the company's standing. Just look back at the Benzinga interviews; that laughably horrific Jose and Lebby video at LWLG HQ, with Lebby sitting at a tiny chemistry table looking like he
LWLG

Su Consulta Reciente

EU
AGN
Aegon
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados